About TTS Pharma
TTS Pharma is a company based in Liverpool (United Kingdom) founded in 2012. It operates as a B2B2C and White Labeling. TTS Pharma has raised $13.94 million across 3 funding rounds from investors including The North West Fund. The company has 6 employees as of December 31, 2020. TTS Pharma offers products and services including CBD for Cosmetics, CBD for Food Supplements, Food and Beverages, and White Labelling. TTS Pharma operates in a competitive market with competitors including Ergomed and Celadon Pharmaceuticals, among others.
- Headquarter Liverpool, United Kingdom
- Employees 6 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Tts Pharma Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.94 M (USD)
in 3 rounds
-
Latest Funding Round
$13.51 M (USD), Post-IPO
Feb 02, 2022
- Investors
-
Employee Count
6
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TTS Pharma
TTS Pharma offers a comprehensive portfolio of products and services, including CBD for Cosmetics, CBD for Food Supplements, Food and Beverages, and White Labelling.
Cannabinoid products are developed for cosmetic industry applications.
Cannabinoid supplements are produced for dietary health benefits.
Cannabinoid ingredients are supplied for food and beverages.
White labelling services are offered for cannabinoid products.
People of TTS Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of TTS Pharma
TTS Pharma has successfully raised a total of $13.94M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $13.51 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TTS Pharma
TTS Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The North West Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm
|
Locked | Locked | Locked |
Investor details for TTS Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TTS Pharma
Investment portfolio details for TTS Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TTS Pharma
Detailed financials for TTS Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tts Pharma Comparisons
Peer comparison for TTS Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TTS Pharma
TTS Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ergomed and Celadon Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Full-service CRO operations are focused on oncology and complex trials.
|
|
| Locked | Locked | Locked |
Provider of cannabis trial services
|
Detailed competitors of TTS Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tts Pharma
Complete news archive for TTS Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TTS Pharma
TTS Pharma was founded in 2012.
TTS Pharma is headquartered in Liverpool, United Kingdom.
TTS Pharma is a funded company, having raised a total of $13.94M across 3 funding rounds to date.
As of Dec 31, 2020, the latest employee count at TTS Pharma is 6.
TTS Pharma Limited, based in the UK, is focused on the production of high-quality, safe Cannabinoid products for the ethical cannabis market. Operations are conducted within the legal frameworks of the UK and Europe, adhering to regulations set by the Home Office, Food Standards Agency, and Trading Standards. Products are developed for sectors including food, cosmetics, and nutraceuticals, with an ambition to become a leading European supplier. Advanced extraction technologies are utilized to purify components for use as Active Pharmaceutical Ingredients (API). Emphasis is placed on supply chain transparency to ensure consumer and patient trust.
TTS Pharma's top competitors include Celadon Pharmaceuticals and Ergomed.
TTS Pharma offers CBD for Cosmetics, CBD for Food Supplements, Food and Beverages, and White Labelling.
TTS Pharma has 1 investor. Key investors include The North West Fund.